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ABSTRACT
Background: The diagnosis of ischemic cardiomyopathy is 
frequently difficult. Coronary angiography (CA) is limited be-
cause it is invasive and the evaluation is exclusively anatomic. 
Cardiac magnetic resonance imaging (MRI) with late gadolinium 
enhancement (LGE) measures patterns of myocardial fibrosis 
caused by ischemia. However, LGE does not detect ischemia 
that does not result in fibrosis. Thus, a thorough clinical 
evaluation by a cardiologist seems to be the most effective 
option for diagnosis. The aim of this study was to evaluate 
CA and LGE as complementary methods for the diagnosis of 
ischemic cardiomyopathy in patients with systolic heart failure 
of unknown etiology. Methods: Patients with systolic heart 
failure, left ventricle ejection fraction < 45% and unknown 
etiology after initial non-invasive evaluation were submitted to 
CA and MRI with LGE to define the etiology of the disease. 
Patient evaluation by two cardiologists was the gold standard 
for the diagnosis of ischemic cardiomyopathy. Results: Twenty-
four patients were included. The sensitivity to detect ischemic 
cardiomyopathy was 0.45 for CA vs. 0.81 for LGE. The speci-
ficity was 1.0 for CA vs. 0.84 for LGE. The positive predictive 
value was 1.0 vs. 0.81 and the negative predictive value was 
0.68 vs. 0.84 for CA and LGE, respectively. LGE accuracy 
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RESUMO
Utilidade Clínica da Angiografia Coronária e da 
Ressonância Nuclear Magnética no Diagnóstico da 
Cardiomiopatia Isquêmica
Introdução: O diagnóstico da cardiomiopatia isquêmica é 
frequentemente difícil. A angiografia coronária (AC) é limitada, 
por ser invasiva e de avaliação exclusivamente anatômica. A 
ressonância nuclear magnética cardíaca (RNM) com realce 
tardio pelo gadolínio (RTG) pode mensurar padrões de fibrose 
miocárdica ocasionados pela isquemia. Porém, o RTG pode 
não detectar isquemia que não resultou em fibrose. Assim, uma 
avaliação clínica meticulosa pelo cardiologista parece ser a 
maneira mais eficaz para definir o diagnóstico. O objetivo deste 
estudo foi avaliar a AC e o RTG como métodos complementares 
para o diagnóstico de cardiomiopatia isquêmica em pacientes 
com insuficiência cardíaca sistólica sem etiologia definida. 
Métodos: Pacientes com insuficiência cardíaca sistólica, fração 
de ejeção do ventrículo esquerdo < 45% e etiologia indefinida 
após avaliação não invasiva inicial foram submetidos à AC e à 
RNM com RTG para definição etiológica. A análise dos casos 
por dois cardiologistas foi o padrão-ouro para o diagnóstico 
de cardiomiopatia isquêmica. Resultados: Foram incluídos 24 
pacientes. A sensibilidade para detecção de cardiomiopatia 
isquêmica foi de 0,45 para AC vs. 0,81 do RTG. A especifi-
cidade da AC foi de 1,0 vs. 0,84 do RTG. O valor preditivo 
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The aim of this study was to evaluate the usefulness 
of MRI with LGE and CA for the diagnosis of ischaemic 
cardiomyopathy in patients with systolic heart failure 
heart of unknown etiology.
METHODS
This is a cross-sectional, single-center study per-
formed at a tertiary care institution of high complexity 
cardiology. The research was based on the analysis of 
databases and medical chart review. 
Study Population
The present study analized data from patients treated 
in the outpatient clinic for treatment of heart failure 
of Instituto do Coração do Hospital das Clínicas da 
Faculdade de Medicina da Universidade de São Paulo, 
between 1 January 2009 and 31 July 2012. Patients 
who underwent CA and MRI with LGE in this period 
to evaluate the etiology of dilated cardiomyopathy of 
unknown cause were included. The inclusion criteria 
were: presence of systolic heart failure, characterized 
by left ventricular ejection fraction (LVEF) < 45%, docu-
mented by echocardiography in the period up to one 
year after the procedure; onset of heart failure symptoms 
for more than one month, and age ≥ 18 years. Patients 
with prior history of CAD, positive serology for Chagas 
disease, valvular heart disease, or heart transplantation 
were excluded from the analysis. 
Procedures
The indication for CA was defined by the criteria 
of the attending physicians and follows the recom-
mendations of current guidelines for chronic heart 
failure,2 which recommend the method for symptom-
atic patients due to angina or persistent heart failure 
(e.g., New York Heart Association [NYHA] functional 
class II, III or IV, despite optimized drug treatment) 
or asymptomatic patients with the presence of two 
or more risk factors for CAD (age > 45 years for 
men and 55 for women; hypercholes terolemia; smok-
ing, systemic arterial hypertension, chronic renal 
disease, or diabetes mellitus). After the CA, patients 
were classified as having ischemic or non-ischemic 
was superior to CA accuracy (0.83 vs. 0.75). Conclusions: 
LGE was more sensitive than CA to evaluate the etiology of 
ventricular dysfunction, whereas CA was more specific. The 
diagnosis of ischemic cardiomyopathy using each one of the 
methods separately presented limitations.
 
 
DESCRIPTORS: Myocardial ischemia. Coronary angiography. 
Magnetic resonance imaging. Diagnosis.
I schemic heart disease is responsible for approxi-mately two-thirds of systolic heart failure cases in the United States,1 and is also currently the main 
cause of systolic heart failure in Brazil.2,3 Although the 
mortality associated with ischemic heart disease has 
decreased in recent decades due to pharmacological 
advances and interventional treatment, it still remains 
the leading cause of death in developed countries.4 
Differentiation of cardiomyopathies, from the etiologi-
cal point of view, can be decisive for decision-making 
in clinical practice due to a number of reasons. First, 
patients with ischemic cardiomyopathy have the worst 
prognosis when compared to other cardiomyopathies.5 
Additionally, ventricular dysfunction of ischemic cause may 
require specific treatment, both through coronary artery 
bypass grafting (CABG) procedures and pharmacological 
treatment for secondary prevention, with statins and 
acetylsalicylic acid. Patients with systolic heart failure 
are considered to have ischemic etiology when they 
show angiographic evidence of prior coronary artery 
disease (CAD), percutaneous coronary intervention or 
CABG, or history of myocardial infarction.
Coronary angiography (CA) is the procedure of 
choice for the detection of coronary artery stenosis in 
patients with systolic heart failure with undefined etiol-
ogy.6 However, it has the limitation of being an invasive 
method, with potential complications and exclusively 
anatomical evaluation. Recently, cardiac magnetic reso-
nance imaging (MRI) with late gadolinium enhancement 
(LGE) technique has become a compelling method 
for the identification of ischemic cardiomyopathy, by 
demonstrating standard patterns of myocardial fibrosis. 
LGE can clearly delineate sub endocardial infarction and 
evaluate the transmural extent of the infarction area.7 
However, despite aggregating a great deal of information, 
LGE evaluation also has the limitation of not detecting 
ischemia that did not result in fibrosis. Thus, the global 
clinical assessment by the cardiologist, with access to all 
methods, appears to be the most effective way to detect 
the biases of each of these methods, and to define the 
diagnosis of ischemic cardiomyopathy. Therefore, the role 
of MRI with LGE and CA as complementary methods 
is yet to be established for the etiologic diagnosis of 
ischemic cardiomyopathy in patients with systolic heart 
failure of unknown cause. 
positivo foi de 1,0 vs. 0,81, e o valor preditivo negativo foi 
0,68 vs. 0,84 para AC e do RTG, respectivamente. A acurácia 
do RTG foi superior a da AC (0,83 vs. 0,75). Conclusões: O 
RTG foi mais sensível do que a AC na avaliação etiológica 
da disfunção ventricular, enquanto a AC foi mais específica. 
A definição de cardiomiopatia isquêmica utilizando cada um 
dos métodos em separado apresentou limitações.
DESCRITORES: Isquemia miocárdica. Angiografia coronária. 
Imagem por ressonância magnética. Diagnóstico.
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etiology. As for the angiographic criteria for ischemic 
cardiomyopathy, previously published definitions were 
used, considering as ischemic etiology patients with 
obstructive lesions (≥ 75 %) in left main coronary 
artery or proximal anterior descending branch, or in 
two or more epicardial vessels.8
All patients included in the study had undergone 
MRI with LGE. The LGE pictures were acquired during 
respiratory pauses and coupled to the electrocardiogram, 
with the following guidelines: two chambers, long axis, 
four chambers, long axis, left ventricular outflow tract, 
and short-axis images with scanning of the entire left 
ventricle. Gadolinium was used as contrast at a dose 
of 0.2 mmoL/kg, and image acquisition was performed 
10 minutes after the infusion.
Global analysis of cases by two clinical cardiologists, 
including all data inclinical history and laboratory tests 
available in medical records, was defined as the gold 
standard for the diagnosis of ischemic cardiomyopathy. 
Data collection and statistical analysis
Demographic data, as well as information on the 
presence of traditional risk factors for CAD were col-
lected. Continuous variables were expressed as means 
and standard deviations, and categorical variables were 
described as percentages. To evaluate the diagnostic 
performance of each method, measures of sensitivity, 
specificity, and predictive values and accuracy were 
calculated, considering the global assessment performed 
by the cardiologists as the gold standard.
RESULTS
 A total of 1,955 consecutive patients were evaluated. 
After applying the study eligibility criteria, 24 patients 
were included in the analysis, of whom 19 (79.2%) were 
males; mean age was 51.6 ± 12.5 years and LVEF was 
27% ± 11.1%. The demographic data of this population 
are shown in Table 1. According to the global clinical as-
sessment, 11 (45.8%) patients were classified as ischemic 
cardiomyopathy and 13 (54.2 %) as non-ischaemic car-
diomyopathy. At the CA, 5 (20.8%) patients had coronary 
obstructions consistent with ischaemic cardiomyopathy and 
19 (79.2%) had no major lesions (Table 2). LGE detected 
subendocardial or transmural pattern compatible with 
ischaemic cardiomyopathy in 11 (45.8%) patients, while 
13 (54.2%) did not have LGE or showed an enhancement 
pattern different from CAD (e.g. mesocardic fibrosis), as 
shown in Table 3.
The variables of the diagnostic performance as-
sessment for the methods used to define ischemic 
cardiomyopathy are described in Table 4.
There was agreement between the methods in 16 
(66.6%) patients, whereas in eight (33.4%), CA and 
LGE were discordant for the detection of ischemic 
cardiomyopathy.
TABLE 1  
Basal characteristics of the population
Variable Result
Male gender, n (%) 19 (79.2)
Age, years, n (%) 51.6 ± 12.5
Diabetes mellitus, n (%) 7 (29.2)
Hypertension, n (%) 13 (54.2)
Smoking, n (%) 7 (29.2)
Family history of CAD, n (%) 4 (16.7)
Chronic renal disease, n (%) 3 (12.5)
Ejection fraction of the left ventricle, 
n (%)
27.0 ± 11.1
NYHA functional class 3-4, n (%) 12 (50)
Angina, n (%) 2 (8.3)
Total cholesterol, mg/dL 171.9 ± 38.4
LDL cholesterol, mg/dL 104.7 ± 30.8
HDL cholesterol, mg/dL 40.5 ± 9.6
Triglycerides, mg/dL 128.6 ± 54.7
CAD = coronary artery disease; NYHA = New York Heart 
Association; LDL = low-density lipoprotein; HDL = high-density 
lipoprotein.
TABLE 2  










Ischemic, n 5 0 5
Non-ischemic, n 6 13 19
Total, n 11 13 24
TABLE 3  
Diagnostic performance of cardiac magnetic 
resonance imaging with late gadolinium 









Ischemic, n 9 2 11
Non-ischemic, n 2 11 13
Total, n 11 13 24
MRI with LGE = magnetic resonance imaging with late 
gadolinium enhancement.
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According to the current heart failure guidelines, 
the CA should be considered in the etiologic assessment 
of patients with systolic heart failure in the presence 
of risk factors for CAD, symptoms of refractory heart 
failure, or angina.6 In this population, the performance 
of the CA, according to these criteria, confirmed the 
ischemic etiology of cardiomyopathy in five (20.8 %) 
patients, but only in four did the MRI show the de-
layed enhancement pattern compatible with ischaemic 
cardiomyopathy. This finding can be explained by the 
possibility that the ventricular dysfunction was due to 
myocardial hibernation. That is, the loss of contractile 
function can be due to cardiac muscle hibernation 
caused by severe coronary obstruction, without cell death 
and formation of necrotic tissue. Similar findings were 
published in a series of 291 patients with biventricular 
dysfunction and no history of acute myocardial infarc-
tion submitted to CA and endomyocardial biopsy due 
to progressive systolic heart failure symptoms.9 Seven 
(2.4%) had significant obstructive lesions at the CA, 
but the endomyocardial biopsy, in all cases, showed 
histological alterations with conclusive criteria for myo-
carditis, demonstrating, once again, that the presence 
of severe coronary obstruction does not necessarily 
have a causal relationship with ventricular dysfunction. 
Conversely, among the remaining 19 (79.1%) patients 
in whom CA did not show alterations consistent with 
ischemic cardiomyopathy, 7 (29.1%) showed transmu-
ral or subendocardial LGE pattern when myocardial 
necrosis was due to ischemia of the heart muscle. 
This finding corroborates the physiopathological ra-
tionale that the infarcted area identified by MRI may 
have been consequent to a transient coronary flow 
obstruction in a time period prior to CA. Brener et al.10 
has demonstrated that approximately 18% of patients 
who had an acute myocardial infarction experienced 
spontaneous recanalization of the artery responsible 
for the event, with TIMI 3 flow, when submitted to 
cardiac catheterization. This can be explained, among 
other possibilities, by thrombolysis through action of 
the endogenous fibrinolytic system. Thus, this aspect 
emphasizes the limitations of CA when used with the 
objective of evaluating the ischemic component of 
systolic heart failure. Similar findings to those of the 
present population have been reported in the literature 
in studies with MRI in patients with dilated cardiomy-
opathy and CA without obstructive lesions, in which 
13% had LGE patterns indistinguishable from those 
seen in CAD.11
The prognostic value of MRI in patients with an 
established diagnosis of ischemic ventricular dysfunc-
tion has been previously demonstrated. In patients with 
ischemic cardiomyopathy and substantial reduction in 
LVEF, the length of the LGE is associated with increased 
mortality, and the need for cardiac transplantation.4 
Representing a non-invasive method with a low rate of 
adverse events, it may be of interest to indicate MRI 
instead of CA, in the initial diagnostic approach of 
systolic heart failure. That is because, although the risk 
of major complications is low when CA is performed 
with diagnostic purpose in unselected patients from 
experienced centers,12 patients with cardiomyopathy 
or heart failure symptoms have increased complication 
likelihood, which increases the risk of adverse events 
by 3.3 – and 2.2-fold, respectively.13 In the present 
study, the rate of complications related to the procedure 
was not evaluated. Another possible indication of MRI 
could be in subgroups of patients in which the lower 
diagnostic power of CA is known, as demonstrated by 
the publication of Melo et al.14 This study of 107 pa-
tients undergoing CA to rule out ischemic heart disease 
as the etiology of left ventricular dysfunction showed 
that the CA had a good diagnostic result for ischemic 
cardiomyopathy only when indicated in symptomatic 
patients with angina or refractory heart failure symptoms. 
When performed in asymptomatic patients with two or 
more risk factors for CAD, there was no diagnosis of 
IC (ischemic cardiomyopathy).14
However, the potential benefit of LGE as an 
isolated test was not observed in this study. As gado-
linium has the capacity to occupy the myocardial 
extracellular space, with increased concentration 
in areas that suffered myocardial necrosis,15 it was 
not possible to identify patients with severe coro-
nary artery lesions at the CA that did not undergo 
cell apoptosis (hibernating myocardium). Therefore, 
although the ischemic etiology has been identified 
in patients with normal CA, the LGE did not detect 
some patients considered to have ischemic cardio-
myopathy, according to the CA criteria used as the 
default method in most clinical studies.
Thus, considering that the two methods are not 
likely to detect ischemic cardiomyopathy as the cause 
of ventricular dysfunction due to the afore mentioned 
reasons, it is possible that the association between the 
two tests is a strategy with greater capacity to identify 
TABLE 4  







Positive predictive value 0.81 1.00
Negative predictive value 0.84 0.68
Accuracy 0.83 0.75
MRI with LGE = magnetic resonance imaging with latega-
dolinium enhancement, CA = coronary angiography.
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individuals with ischemic cardiomyopathy. Moreover, 
this study considered the clinical assessment by two 
cardiologists as the gold standard for the diagnosis of 
ischemic cardiomyopathy. This allowed the biases of 
each method to be identified when classifying individuals 
regarding the presence or absence of ischemic ventricular 
dysfunction. To illustrate this fact, in one case of this 
study, a male patient with severe left ventricular dysfunc-
tion at the expense of diffuse hypokinesis at the MRI 
showed no lesions at the CA, and LGE with transmural 
fibrosis in the apical and antero apical segments. This 
case would be classified as ischemic cardiomyopathy 
by the LGE, and as a non-ischemic case according to 
the CA. However, considering that the patient had no 
clinical history consistent with myocardial infarction 
and that the presence of fibrosis, albeit transmural, in 
a small and distal segment of the ventricle would not 
justify the diffuse contractile dysfunction, the global 
clinical evaluation defined this case as non-ischemic 
heart disease.
Although the findings of this study are quite com-
patible with previous publications in this area, this 
method of measuring the gold standard for ischemic 
cardiomyopathy, throughthe clinical independent as-
sessment of two cardiologists, makes this a pioneering 
analysis among diagnostic studies of ischemic ventricular 
dysfunction.
Study limitations
This study has some limitations. This is a retrospec-
tive review subject to inherent biases of this modal-
ity, such as obtaining data on epidemiology and the 
indication of the CA. The study was carried out in one 
center and with a convenience sample, referred from 
a tertiary hospital with a limited number of patients 
included in the analysis.
CONCLUSIONS
In this study, cardiac magnetic resonance imaging 
with late gadolinium enhancement was more sensitive 
than coronary angiography in the etiological assessment 
of left ventricular dysfunction of unknown cause. The 
coronary angiography, in turn, was more specific. The 
definition of ischemic cardiomyopathy using each one 
of the methods separately showed limitations. These two 
assessments showed that they were complementary in 
the etiological diagnosis of heart failure.
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